NCT05225025

Brief Summary

This study is a pilot, single-center, randomized controlled trial. It will

  1. 1.determine feasibility and acceptability of an evidence-based intervention for prevention of postpartum depression with antepartum patients on a high-risk obstetric unit,
  2. 2.determine what adaptations may be needed for an inpatient population
  3. 3.determine what retention strategies are most successful and acceptable for this patient population
  4. 4.estimate the effect size of an intervention for in-hospital distress, anxiety and depression
  5. 5.estimate the effect size of an intervention to reduce the risk of a post-partum depression diagnosis or depressive symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 5, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 7, 2022

Completed
28 days until next milestone

First Posted

Study publicly available on registry

February 4, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2022

Completed
Last Updated

June 13, 2022

Status Verified

June 1, 2022

Enrollment Period

10 months

First QC Date

January 7, 2022

Last Update Submit

June 9, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Subject-reported in-hospital distress

    Hospital distress will be measured using the Depression, Anxiety and Stress Scale-21 (DASS-21) Stress subscale. Stress subscale ranges from 0 to 42 with higher scores indicating worse outcome.

    14 days

  • Subject-reported depressive symptom severity

    Depressive symptom severity will be measured using the Edinburgh Postnatal Depression Scale (EPDS). The scale ranges from 0-30 with higher scores indicating worse outcome.

    6 weeks postpartum

  • Subject-reported anxiety symptom severity

    Anxiety symptom severity will be measured using the General Anxiety Disorder-7 (GAD-7) measurement scale. The scale ranges from 0 to 21 with higher scores indicating worse outcome.

    6 weeks postpartum

  • Clinical diagnosis of depression

    Diagnosis of depression will be made using the Mini International Neuropsychiatric Interview (M.I.N.I) brief structured diagnostic interview which explores, in a standardized way, the main psychiatric disorders of Axis I of the DSM-IV TR. Only modules A and B (Major depressive episode and dysthymia) will be used. This structured interview contains questions with binary answers, with Yes indicating worse outcome.

    6 weeks postpartum

Other Outcomes (6)

  • satisfaction with ROSE behavioral health intervention

    14 days and 6 weeks postpartum

  • self-reported mother-infant bonding

    6 weeks postpartum

  • self-reported functional status

    6 weeks postpartum

  • +3 more other outcomes

Study Arms (2)

ROSE Intervention

EXPERIMENTAL
Behavioral: ROSE

Standard of Care

ACTIVE COMPARATOR
Other: Standard of Care

Interventions

ROSEBEHAVIORAL

The ROSE (Reach Out, Stay Strong, Essentials for mothers of newborns) program is an evidence-based intervention that has been proven to reduce cases of post-partum depression among low-income and racially and ethnically diverse women. ROSE is administered to pregnant women in small group settings, typically in the same location that prenatal care is being provided (in this study, a hospital setting). It is divided into four 90-minute group sessions and teaches interpersonal psychotherapy-based skills that mitigate identified risk factors for PPD such as social support, stress management skills and communication. ROSE curriculum will be implemented using groups in a continuous cycle, with patients entering into the intervention curriculum at the time of their enrollment and continuing through until all 4 total sessions have been accomplished.

ROSE Intervention

Usual hospital care with no behavioral intervention

Standard of Care

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Viable pregnancy between 20 weeks 0 days and 35 weeks 0 days gestation at the time of enrollment
  • Anticipated admission to the hospital for \>5 days due to pregnancy complication requiring hospital observation
  • Age \> 18 years
  • Planned hospitalization at Strong Memorial Hospital through the duration of antepartum course
  • Planned delivery at Strong Memorial Hospital

You may not qualify if:

  • Fetal demise in utero
  • Inability to give informed consent secondary to intellectual capacity
  • English is not primary language used to communicate
  • Currently incarcerated
  • Age \< 18 years
  • Planned antepartum hospitalization at another institution
  • Planned delivery at another institution
  • Actively suicidal or in need of acute psychiatric care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Strong Hospital

Rochester, New York, 14642, United States

Location

MeSH Terms

Conditions

Depression, Postpartum

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 7, 2022

First Posted

February 4, 2022

Study Start

July 5, 2021

Primary Completion

May 2, 2022

Study Completion

May 2, 2022

Last Updated

June 13, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations